Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Obesity paradox in atrial fibrillation: a distracting reality or fictitious finding?|
|Citation:||European Heart Journal, 2016; 37(38):2879-2881|
|Publisher:||Oxford University Press|
|Dennis H. Lau, Melissa E. Middeldorp, and Prashanthan Sanders|
|Abstract:||This editorial refers to ‘The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial’†, by R.K. Sandhu et al., on page 2869.|
|Keywords:||Humans; Atrial Fibrillation; Obesity; Body Mass Index; Risk Factors|
|Description:||Online publish-ahead-of-print 17 July 2016|
|Rights:||© The Author 2016. Published on behalf of the European Society of Cardiology. All rights reserved.|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.